AZURITY PHARMACEUTICALS
Updated 50 days ago
Azurity Pharmaceuticals, Inc. was formerly known as CutisPharma, Inc. Product labeling and imagery are for representation purposes only and may reflect either name...
Severe dermatologic reactions such as toxic epidermal necrolysis (TEN), Stevens-Johnson syndrome (SJS), drug reaction with eosinophilia and systemic symptoms (DRESS), acute generalized exanthematous pustulosis (AGEP), and linear lgA bullous dermatosis (LABD) have been reported in association with the use of vancomycin. Cutaneous signs or symptoms reported include skin rashes, mucosal lesions, and blisters. Discontinue FIRVANQ at the first appearance of signs and symptoms of TEN, SJS, DRESS, AGEP, or LABD.
Also known as: Azurity Pharmaceuticals, Inc.